IL17A and Alzheimer disease: Emerging evidence suggests that type 3 immunity, characterized by the production of Th17-related cytokines (e.g., IL-17A) and the recruitment of neutrophils, is also involved in AD development, especially in intrinsic, pediatric or Asian patients, by fueling the type 2 immune response [3, 8, 12, 13].